Edition:
India

Zhejiang Hisun Pharmaceutical Co Ltd (600267.SS)

600267.SS on Shanghai Stock Exchange

16.17CNY
--
Change (% chg)

-- (--)
Prev Close
¥16.17
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
6,340,410
52-wk High
¥16.70
52-wk Low
¥10.24

Chart for

About

Zhejiang Hisun Pharmaceutical Co., Ltd. is a China-based company, principally engaged in the research and development, manufacture and distribution of specialty bulk pharmaceutical chemicals and preparation products. The Company's bulk pharmaceutical chemicals mainly include antineoplastic drugs, cardiovascular drugs, anti-infec... (more)
No analyst recommendations are available for .

Overall

Beta: 1.17
Market Cap(Mil.): ¥12,262.25
Shares Outstanding(Mil.): 965.53
Dividend: 0.05
Yield (%): 0.39

Financials

  Industry Sector
P/E (TTM): -- 31.15 16.44
EPS (TTM): -- -- --
ROI: -- 14.99 10.62
ROE: -- 16.33 14.20

Pfizer exits China joint venture for generic drugs

Nov 10 Pfizer Inc said on Friday it has sold its 49 percent stake to exit a joint venture it had set up with China's Zhejiang Hisun Pharmaceuticals in 2012 to develop and market generic drugs.

11 Nov 2017

BRIEF-Zhejiang Hisun Pharmaceutical receives TGA-GMP certificate

* Says it received goods manufacture practice (GMP) certificate from Therapeutic Goods Administration

11 Oct 2017

BRIEF-Zhejiang Hisun Pharmaceutical to invest 5.1 mln yuan to set up investment management JV

* Says it will invest 5.1 million yuan to set up Zhejiang-based investment management JV, which will be engaged in operation of pharmaceutical industry innovation projects, and hold 51 percent stake in JV after transaction

27 Sep 2017

BRIEF-Zhejiang Hisun Pharmaceutical plans to sell stake in Germany's INS

* Says it plans to sell its entire 21.05 percent stake in Germany's IMD Natural Solutions GmbH (INS)

26 Sep 2017

BRIEF-Zhejiang Hisun Pharmaceutical sub-subsidiary passes FDA approval

* Says its Zhejiang-based sub-subsidiary received FDA approval for metformin sustained release tablet from U.S Food and Drug Administration

11 Sep 2017

BRIEF-Zhejiang Hisun Pharma cuts share issue size

* Says it cuts share issue size to 940.92 million yuan ($142.72 million) from 1.17 billion yuan previously

30 Aug 2017

BRIEF- Zhejiang Hisun Pharmaceutical to set up pharmaceutical unit in Zhejiang

* Says it plans to set up a wholly owned pharmaceutical unit in Zhejiang, with registered capital of 10 million yuan

11 Aug 2017

BRIEF-Zhejiang Hisun Pharmaceutical to pay FY 2016 annual div on July 7

* Says it will pay FY 2016 dividend to shareholders of record on July 6

30 Jun 2017

BRIEF-Zhejiang Hisun Pharmaceutical receives GMP certificate

* Says it received goods manufacture practice (GMP) certificate from Zhejiang Food and Drug Administration

28 Jun 2017

Earnings vs. Estimates